hydroxychloroquine has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morlacchi, LC | 1 |
| Rossetti, V | 1 |
| Gigli, L | 1 |
| Amati, F | 1 |
| Rosso, L | 1 |
| Aliberti, S | 1 |
| Nosotti, M | 1 |
| Blasi, F | 1 |
| Manning, EP | 1 |
| Losier, A | 1 |
| Emeagwali, N | 1 |
| Ryu, C | 1 |
| Honiden, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the SARS-CoV2 Vaccine in Solid Organ Transplantation (Lung and / or Liver) Adult Recipients[NCT05116748] | 200 participants (Anticipated) | Observational | 2021-10-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for hydroxychloroquine and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
COVID-19 in lung transplant recipients: A case series from Milan, Italy.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Blood Gas Analysis; COVID-19; COVID-19 Drug Treatment; | 2020 |
New Applications of Old Drugs as Novel Therapies in Idiopathic Pulmonary Fibrosis. Metformin, Hydroxychloroquine, and Thyroid Hormone.
Topics: Bleomycin; Humans; Hydroxychloroquine; Idiopathic Pulmonary Fibrosis; Metformin; Thyroid Hormones | 2019 |